Last update :
27/11/2024
References   References 3646  
Type : Manufacturer

Research teams :
Authors :
Title : Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit
Reference : Sanofi Aventis France 2013

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionAminophylline Various
Incompatible + injectionBleomycin sulfate
injectionAscorbic acid Vitamin
Incompatible + injectionBleomycin sulfate
injectionBleomycin sulfate Anticancer drug
Stability in solutions Glass Sodium chloride 0,9% 3 mg/ml 2-8°C Not specified
24 Hour
Incompatible + injectionAminophylline
Incompatible + injectionAscorbic acid
Incompatible + injectionDexamethasone sodium phosphate
Incompatible + injectionFurosemide
injectionDexamethasone sodium phosphate Anti-inflammatory
Incompatible + injectionBleomycin sulfate
injectionFurosemide Diuretic
Incompatible + injectionBleomycin sulfate

  Mentions Légales